Literature DB >> 7005295

Changes in endocrine activities relative to obesity in patients with essential hypertension.

K Hiramatsu, T Yamada, K Ichikawa, T Izumiyama, H Nagata.   

Abstract

The possible role of obesity in the development of hypertension was investigated in two study groups. In a population study of 961 subjects, 739 were found to be normotensive and 222 hypertensive. The prevalence of hypertension was 18.7 percent in the nonobese, and 33.2 percent in the obese subjects. Systolic and diastolic blood pressures increased progressively with the increase of relative body weight in both normotensive and hypertensive subjects. In addition, an endocrinologic study was made of 97 patients with essential hypertension; in 82, plasma renin activity (PRA) was inversely correlated with the increase of relative body weight but not with urinary Na excretion. Despite this decrease of PRA, the level of serum aldosterone was not influenced by relative body weight. Thus, the aldosterone/PRA ratio ratio increased progressively with the increase of relative body weight. Thiazide therapy normalized this inappropriately high ratio, and reduced body weight and blood pressure. Restriction of dietary calories and salt intake had a similar effect. With a high-salt intake in an obese subject, the aldosterone/PRA ratio is unduly increased. Apparently aldosterone contributes to the additional retention of sodium and water and thereby promotes hypertension in the presence of an expanded fluid volume.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7005295     DOI: 10.1111/j.1532-5415.1981.tb02389.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  13 in total

Review 1.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  Complex interactions in complex traits: obesity and asthma.

Authors:  K G Tantisira; S T Weiss
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

4.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

Review 5.  Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.

Authors:  Laura D Kubzansky; Gail K Adler
Journal:  Neurosci Biobehav Rev       Date:  2009-07-22       Impact factor: 8.989

6.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 7.  The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease.

Authors:  Jessica L Faulkner; Thiago Bruder-Nascimento; Eric J Belin de Chantemèle
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

8.  Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).

Authors:  Yewei Xing; William E Rainey; John W Apolzan; Omar L Francone; Ruth B S Harris; Wendy B Bollag
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

Review 9.  Obesity, sleep apnea, aldosterone, and hypertension.

Authors:  Theodore L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 10.  Physical activity in human hypertension. A mechanisms approach.

Authors:  W L Kenney; E J Zambraski
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.